Results 201 to 210 of about 43,194 (232)
Some of the next articles are maybe not open access.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
Lancet, The, 2021 Anthony Guy Marson, Girvan Burnside, David Smith +2 moreexaly